Hemoperfusion: Indications, Dose, Prescription
Contributions to Nephrology · 2023
DOI: 10.1159/000529294 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Contributions to Nephrology, 2023. Verfasst von Frank Bidar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France. Hauptthemen laut MEDLINE: Hemoperfusion, Sepsis, Rhabdomyolysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care Medicine, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
- EA 7426, Pathophysiology of Injury-Induced Immunosuppression, Hospices Civils de Lyon-Biomérieux-University Claude Bernard Lyon 1, Lyon, France.
- MitoVasc Institut, INSERM 1083 - CNRS 6015, University of Angers, Angers, France.
Zitieren
APA
Bidar, F., Abrard, S., Lamblin, A., & Rimmelé, T. (2023). Hemoperfusion: Indications, Dose, Prescription. Contributions to Nephrology. https://doi.org/10.1159/000529294
Vancouver
Bidar F, Abrard S, Lamblin A, Rimmelé T. Hemoperfusion: Indications, Dose, Prescription. Contributions to Nephrology. 2023. doi:10.1159/000529294
BibTeX
@article{Bidar2023,
author = {Bidar, Frank and Abrard, Stanislas and Lamblin, Antoine and Rimmelé, Thomas},
title = {Hemoperfusion: Indications, Dose, Prescription},
journal = {Contributions to Nephrology},
year = {2023},
doi = {10.1159/000529294}
}
EUVIMED